3 Indian Growth Stocks With Up To 58% Earnings Growth

Rising US Treasury yields near multi decade highs have pushed borrowing costs up globally, which puts steady pressure on richly priced stories and makes investors more selective. That is where fast growing Indian businesses with meaningful insider ownership can look interesting, because committed founders have more skin in the game. This article walks through three such stocks from our high growth, high insider holding list and explains what makes each potentially worth a closer look.

The three stocks below are just a starter sample, and the full screen surfaced 105 more companies with similarly strong growth stories and high insider backing that are not covered here.

If you want to identify, compare, and analyze those additional opportunities in one place, head straight to the Fast Growing Stocks With High Insider Ownership screener.

Rubicon Research (NSEI:RUBICON)

Overview: Rubicon Research is a specialty pharmaceutical developer that uses proprietary drug delivery platforms to build differentiated treatments across high growth therapeutic areas.

Operations: Rubicon Research currently generates about ₹19,358 million in revenue from pharmaceutical products, including generics, specialty drugs, APIs, and related services.

Market Cap: ₹256.3 billion

Rubicon Research fits this fast growing, high insider ownership theme through its focus on specialty formulations built on proprietary drug delivery platforms. Management is actively scaling these platforms across complex therapy areas.

"Consistent R&D investment at roughly 10% to 11% of revenue, together with a track record of commercialising 88% of approved products, points to a deeper product basket that can support future revenue and earnings visibility."

What happens to future margins and cash generation depends heavily on how one concentrated execution risk around that expanding product basket plays out.

That execution swing is exactly what the full narrative for Rubicon Research unpacks, laying out how Rubicon Research’s platform, pipeline mix, and capital choices could reshape that risk reward profile.

Privi Speciality Chemicals (BSE:530117)

Overview: Privi Speciality Chemicals manufactures and exports specialty aroma and fragrance ingredients used in personal care, home care, and perfumery products worldwide.

Operations: Privi Speciality Chemicals currently generates about ₹26,711 million in revenue from aromatic chemicals, primarily linked to its fragrance ingredients portfolio.

Market Cap: ₹133.8 billion

Privi Speciality Chemicals matters for this screener because its aroma chemicals business combines high insider backing with a focused, higher margin growth engine that directly serves everyday consumer brands.

"Acceleration in fragrance and FMCG demand globally and in India, supported by rising consumption of deodorants, detergents, shampoos and other aroma driven products, may support double digit volume growth and revenue compounding relative to current expectations."

The key consideration is how an evolving mix shift inside that aroma portfolio ultimately affects pricing power and margin resilience.

That mix shift question is exactly what the full narrative for Privi Speciality Chemicals unpacks. It highlights where accelerating aroma demand, capacity choices, and insider backing could still be mispriced by the market.

Bajel Projects (NSEI:BAJEL)

Overview: Bajel Projects runs EPC contracts for extra high voltage transmission and distribution lines, backed by high insider ownership and large infrastructure orders.

Operations: Bajel Projects generates approximately ₹27,508 million in revenue from power transmission and power distribution EPC work and related infrastructure services.

Market Cap: ₹18.2 billion

Bajel Projects ties neatly into this fast growth and insider backed screener through large EHV transmission contracts, 57.67% forecast annual earnings growth, and a 27% revenue CAGR outlook, all against an 82.5x P/E that already prices in a lot of success. This raises the question of what could happen if a single pressure point in those mega EPC projects changes the path of margins or cash conversion.

If that EPC execution swing interests you, the analysis report for Bajel Projects highlights where Bajel Projects’ rich P/E could still be underrating contract risk and potential upside inflection.

Curious About What You Might Be Missing?

Fresh ideas often move first. Breakout trends, early momentum, and under-the-radar stories can change quickly once the crowd arrives, so review these curated lists and consider them promptly.

• Look for potential turnaround leaders before their stories move into the spotlight by reviewing the curated 618 high quality undiscovered gems while they are still under the radar.
• Identify income candidates that seek to maintain steady cash flows by tracking the curated 223 dividend fortresses while yields still look appealing.
• Explore structural demand for secure transaction rails by scanning the curated 20 cryptocurrency and blockchain stocks while it still reflects early-stage adoption rather than later phases of market attention.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com